vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and ZIPRECRUITER, INC. (ZIP). Click either name above to swap in a different company.
ZIPRECRUITER, INC. is the larger business by last-quarter revenue ($111.7M vs $94.9M, roughly 1.2× DYNAVAX TECHNOLOGIES CORP). DYNAVAX TECHNOLOGIES CORP runs the higher net margin — 28.4% vs -0.7%, a 29.1% gap on every dollar of revenue. On growth, DYNAVAX TECHNOLOGIES CORP posted the faster year-over-year revenue change (17.7% vs 0.6%). DYNAVAX TECHNOLOGIES CORP produced more free cash flow last quarter ($32.6M vs $7.6M). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs -4.4%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
ZipRecruiter, Inc. is an American employment marketplace for job seekers and employers.
DVAX vs ZIP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $111.7M |
| Net Profit | $26.9M | $-835.0K |
| Gross Margin | — | 89.1% |
| Operating Margin | 22.4% | 3.6% |
| Net Margin | 28.4% | -0.7% |
| Revenue YoY | 17.7% | 0.6% |
| Net Profit YoY | 53.0% | 92.3% |
| EPS (diluted) | $0.21 | $-0.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $111.7M | ||
| Q3 25 | $94.9M | $115.0M | ||
| Q2 25 | $95.4M | $112.2M | ||
| Q1 25 | $68.2M | $110.1M | ||
| Q4 24 | $72.0M | $111.0M | ||
| Q3 24 | $80.6M | $117.1M | ||
| Q2 24 | $73.8M | $123.7M | ||
| Q1 24 | $50.8M | $122.2M |
| Q4 25 | — | $-835.0K | ||
| Q3 25 | $26.9M | $-9.8M | ||
| Q2 25 | $18.7M | $-9.5M | ||
| Q1 25 | $-96.1M | $-12.8M | ||
| Q4 24 | $7.0M | $-10.8M | ||
| Q3 24 | $17.6M | $-2.6M | ||
| Q2 24 | $11.4M | $7.0M | ||
| Q1 24 | $-8.7M | $-6.5M |
| Q4 25 | — | 89.1% | ||
| Q3 25 | — | 89.1% | ||
| Q2 25 | — | 89.3% | ||
| Q1 25 | — | 89.4% | ||
| Q4 24 | — | 89.6% | ||
| Q3 24 | — | 89.4% | ||
| Q2 24 | — | 89.5% | ||
| Q1 24 | — | 89.1% |
| Q4 25 | — | 3.6% | ||
| Q3 25 | 22.4% | -4.4% | ||
| Q2 25 | 15.1% | -5.9% | ||
| Q1 25 | -34.7% | -10.6% | ||
| Q4 24 | -2.3% | -3.6% | ||
| Q3 24 | 12.5% | -2.8% | ||
| Q2 24 | 7.0% | 7.6% | ||
| Q1 24 | -35.0% | -0.7% |
| Q4 25 | — | -0.7% | ||
| Q3 25 | 28.4% | -8.5% | ||
| Q2 25 | 19.6% | -8.5% | ||
| Q1 25 | -141.0% | -11.7% | ||
| Q4 24 | 9.8% | -9.7% | ||
| Q3 24 | 21.8% | -2.2% | ||
| Q2 24 | 15.4% | 5.7% | ||
| Q1 24 | -17.2% | -5.3% |
| Q4 25 | — | $-0.03 | ||
| Q3 25 | $0.21 | $-0.11 | ||
| Q2 25 | $0.14 | $-0.10 | ||
| Q1 25 | $-0.77 | $-0.13 | ||
| Q4 24 | $0.07 | $-0.10 | ||
| Q3 24 | $0.12 | $-0.03 | ||
| Q2 24 | $0.08 | $0.07 | ||
| Q1 24 | $-0.07 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | $188.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $534.1M | $-77.2M |
| Total Assets | $946.5M | $569.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $188.0M | ||
| Q3 25 | $160.2M | $211.8M | ||
| Q2 25 | $99.1M | $203.5M | ||
| Q1 25 | $51.7M | $221.1M | ||
| Q4 24 | $95.9M | $218.4M | ||
| Q3 24 | $119.3M | $225.6M | ||
| Q2 24 | $112.5M | $271.7M | ||
| Q1 24 | $132.0M | $282.5M |
| Q4 25 | — | $-77.2M | ||
| Q3 25 | $534.1M | $-76.1M | ||
| Q2 25 | $494.2M | $-65.9M | ||
| Q1 25 | $530.9M | $-11.3M | ||
| Q4 24 | $596.8M | $13.4M | ||
| Q3 24 | $681.4M | $13.6M | ||
| Q2 24 | $642.8M | $24.4M | ||
| Q1 24 | $618.5M | $12.7M |
| Q4 25 | — | $569.7M | ||
| Q3 25 | $946.5M | $573.6M | ||
| Q2 25 | $918.4M | $592.4M | ||
| Q1 25 | $945.9M | $629.4M | ||
| Q4 24 | $986.3M | $664.1M | ||
| Q3 24 | $1.1B | $652.0M | ||
| Q2 24 | $1.0B | $665.3M | ||
| Q1 24 | $986.6M | $662.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $7.7M |
| Free Cash FlowOCF − Capex | $32.6M | $7.6M |
| FCF MarginFCF / Revenue | 34.4% | 6.8% |
| Capex IntensityCapex / Revenue | 1.3% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.26× | — |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | $9.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $7.7M | ||
| Q3 25 | $33.8M | $2.6M | ||
| Q2 25 | $23.4M | $10.5M | ||
| Q1 25 | $-19.6M | $-9.9M | ||
| Q4 24 | $53.0M | $12.5M | ||
| Q3 24 | $19.5M | $9.3M | ||
| Q2 24 | $10.7M | $21.9M | ||
| Q1 24 | $-16.7M | $2.0M |
| Q4 25 | — | $7.6M | ||
| Q3 25 | $32.6M | $2.2M | ||
| Q2 25 | $22.0M | $10.2M | ||
| Q1 25 | $-23.6M | $-10.2M | ||
| Q4 24 | $49.5M | $12.0M | ||
| Q3 24 | $18.1M | $9.2M | ||
| Q2 24 | $9.9M | $21.7M | ||
| Q1 24 | $-17.4M | $1.9M |
| Q4 25 | — | 6.8% | ||
| Q3 25 | 34.4% | 1.9% | ||
| Q2 25 | 23.0% | 9.1% | ||
| Q1 25 | -34.6% | -9.3% | ||
| Q4 24 | 68.8% | 10.8% | ||
| Q3 24 | 22.5% | 7.8% | ||
| Q2 24 | 13.5% | 17.6% | ||
| Q1 24 | -34.3% | 1.6% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 1.5% | 0.3% | ||
| Q1 25 | 5.8% | 0.3% | ||
| Q4 24 | 4.8% | 0.4% | ||
| Q3 24 | 1.7% | 0.2% | ||
| Q2 24 | 1.1% | 0.1% | ||
| Q1 24 | 1.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.52× | — | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 0.94× | 3.12× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
ZIP
| License | $84.3M | 75% |
| Services | $27.4M | 25% |
